Hardik Mody Selected Research

Estrogen Receptors

1/2019

Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy-apoptosis crosstalk pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hardik Mody Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 04/2015
1	Cardiotoxicity 01/2021
1	Multiple Myeloma 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Triple Negative Breast Neoplasms 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Carcinoma (Carcinomatosis) 04/2015
1	Ovarian Neoplasms (Ovarian Cancer) 04/2015
1	Teratocarcinoma 04/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

2	NucleosidesIBA 04/2015 - 01/2013
2	Pharmaceutical PreparationsIBA 04/2015 - 01/2013
2	Gemcitabine FDA Link 04/2015 - 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	idecabtagene vicleucelIBA 01/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	B-Cell Maturation AntigenIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2019
1	osimertinibIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	PlatinumIBA 04/2015
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 04/2015
1	Histones (Histone)IBA 01/2013
1	3-deazaneplanocinIBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2013